Chronic kidney disease and fragility fracture.
Kazama JJ.
Clin Exp Nephrol. 2017 Mar;21(Suppl 1):46-52. doi: 10.1007/s10157-016-1368-3. Epub 2016 Dec 23.
Phosphate and bone fracture risk in chronic kidney disease patients.
Fusaro M, Holden R, Lok C, Iervasi G, Plebani M, Aghi A, Gallieni M, Cozzolino M.
Nephrol Dial Transplant. 2021 Feb 20;36(3):405-412. doi: 10.1093/ndt/gfz196.
Chronic Intermittent Hypobaric Hypoxia Enhances Bone Fracture Healing.
Zhang L, Jin L, Guo J, Bao K, Hu J, Zhang Y, Hou Z, Zhang L.
Front Endocrinol (Lausanne). 2021 Feb 16;11:582670. doi: 10.3389/fendo.2020.582670. eCollection 2020.
Non-union bone fractures.
Wildemann B, Ignatius A, Leung F, Taitsman LA, Smith RM, Pesántez R, Stoddart MJ, Richards RG, Jupiter JB.
Nat Rev Dis Primers. 2021 Aug 5;7(1):57. doi: 10.1038/s41572-021-00289-8.
Management of Chronic Fracture-Related Infection.
Stroud S, Kandemir U.
Instr Course Lect. 2025;74:421-432.
How to predict and treat increased fracture risk in chronic kidney disease.
West SL, Patel P, Jamal SA.
J Intern Med. 2015 Jul;278(1):19-28. doi: 10.1111/joim.12361. Epub 2015 Apr 16.
Fracture risk assessment in patients with chronic kidney disease.
Jamal SA, West SL, Miller PD.
Osteoporos Int. 2012 Apr;23(4):1191-8. doi: 10.1007/s00198-011-1781-0. Epub 2011 Sep 8.
Does long-term use of tenofovir disoproxil fumarate affect fracture risk in patients with chronic hepatitis B?
Zhang H, Huang J, Zhu W, Feng W, Zeng Y.
J Hepatol. 2024 Oct;81(4):e199-e200. doi: 10.1016/j.jhep.2024.05.040. Epub 2024 Jun 13.
Chronic Osteomyelitis Following a Closed Fracture.
Konda M, Steele RW, Waldron S.
Clin Pediatr (Phila). 2020 Oct;59(12):1101-1104. doi: 10.1177/0009922820935605. Epub 2020 Jul 10.
Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B.
Yip TC, Lai JC, Yam TF, Tse YK, Hui VW, Lai MS, Chan HL, Wong VW, Wong GL.
J Hepatol. 2024 Apr;80(4):553-563. doi: 10.1016/j.jhep.2023.12.001. Epub 2023 Dec 14.
